The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Alexion Pharmaceuticals Inc

Nasdaq: ALXN
Last

(U.S.) $137.73

Today's change+2.43 +1.80%
Updated January 18 9:32 AM EST. Delayed by at least 15 minutes.
 

Alexion Pharmaceuticals Inc

Nasdaq: ALXN
Last

(U.S.) $137.73

Today's change+2.43 +1.80%
Updated January 18 9:32 AM EST. Delayed by at least 15 minutes.

Alexion Pharmaceuticals Inc up sharply

Alexion Pharmaceuticals Inc is up sharply today, rallying (U.S.)$2.43 or 1.80% to (U.S.)$137.73. Over the last five days, shares have gained 0.78%, but are down 13.20% for the last 52 weeks, lagging the 20.67% return in the S&P 500.

Key company metrics

  • Open(U.S.) $136.25
  • Previous close(U.S.) $135.30
  • High(U.S.) $138.47
  • Low(U.S.) $136.25
  • Bid / Ask(U.S.) $136.51 / (U.S.) $137.89
  • YTD % change+12.57%
  • Volume20,750
  • Average volume (10-day)3,167,358
  • Average volume (1-month)3,522,735
  • Average volume (3-month)2,654,307
  • 52-week range(U.S.) $109.12 to (U.S.) $163.71
  • Beta1.40
  • Trailing P/E83.64×
  • P/E 1 year forward29.19×
  • Forward PEG1.75×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.65
Updated January 18 9:32 AM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue799753701701
Total other revenue--------
Total revenue799753701701
Gross profit728692642643
Total cost of revenue71615958
Total operating expense620558535604
Selling / general / administrative230232233242
Research & development196179167191
Depreciation / amortization82808980
Interest expense (income), net operating--------
Unusual expense (income)417-1333
Other operating expenses, total--------
Operating income17919516697
Interest income (expense), net non-operating-----24-23
Gain (loss) on sale of assets--------
Other--------
Income before tax15817014475
Income after tax941159267
Income tax, total6455518
Net income941159267
Total adjustments to net income--------
Net income before extra. items941159267
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items941159267
Inc. avail. to common incl. extra. items941159267
Diluted net income941159267
Dilution adjustment--------
Diluted weighted average shares226226227228
Diluted EPS excluding extraordinary itemsvalue per share0.420.510.410.29
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.530.530.370.42